Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shira Gertz is active.

Publication


Featured researches published by Shira Gertz.


American Journal of Respiratory and Critical Care Medicine | 2015

Developing a clinically feasible personalized medicine approach to pediatric septic shock.

Hector R. Wong; Natalie Z. Cvijanovich; Nick Anas; Geoffrey L. Allen; Neal J. Thomas; Michael T. Bigham; Scott L. Weiss; Julie C. Fitzgerald; Paul A. Checchia; Keith Meyer; Thomas P. Shanley; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J. Freishtat; Jeffrey Nowak; Raj S. Shekhar; Shira Gertz; Emily Dawson; Kelli Howard; Kelli Harmon; Eileen Beckman; Erin Frank; Christopher J. Lindsell

RATIONALE Using microarray data, we previously identified gene expression-based subclasses of septic shock with important phenotypic differences. The subclass-defining genes correspond to adaptive immunity and glucocorticoid receptor signaling. Identifying the subclasses in real time has theranostic implications, given the potential for immune-enhancing therapies and controversies surrounding adjunctive corticosteroids for septic shock. OBJECTIVES To develop and validate a real-time subclassification method for septic shock. METHODS Gene expression data for the 100 subclass-defining genes were generated using a multiplex messenger RNA quantification platform (NanoString nCounter) and visualized using gene expression mosaics. Study subjects (n = 168) were allocated to the subclasses using computer-assisted image analysis and microarray-based reference mosaics. A gene expression score was calculated to reduce the gene expression patterns to a single metric. The method was tested prospectively in a separate cohort (n = 132). MEASUREMENTS AND MAIN RESULTS The NanoString-based data reproduced two septic shock subclasses. As previously, one subclass had decreased expression of the subclass-defining genes. The gene expression score identified this subclass with an area under the curve of 0.98 (95% confidence interval [CI95] = 0.96-0.99). Prospective testing of the subclassification method corroborated these findings. Allocation to this subclass was independently associated with mortality (odds ratio = 2.7; CI95 = 1.2-6.0; P = 0.016), and adjunctive corticosteroids prescribed at physician discretion were independently associated with mortality in this subclass (odds ratio = 4.1; CI95 = 1.4-12.0; P = 0.011). CONCLUSIONS We developed and tested a gene expression-based classification method for pediatric septic shock that meets the time constraints of the critical care environment, and can potentially inform therapeutic decisions.


Pediatric Critical Care Medicine | 2016

Invasive Mechanical Ventilation and Mortality in Pediatric Hematopoietic Stem Cell Transplantation: A Multicenter Study.

Courtney Rowan; Shira Gertz; Jennifer McArthur; Julie C. Fitzgerald; Mara Nitu; Ashley Loomis; Deyin D. Hsing; Christine Duncan; Kris M. Mahadeo; Lincoln S. Smith; Jerelyn Moffet; Mark Hall; Emily L. Pinos; Ira M. Cheifetz; Robert F. Tamburro

Objective: To establish the current respiratory practice patterns in pediatric hematopoietic stem cell transplant patients and investigate their associations with mortality across multiple centers. Design: Retrospective cohort between 2009 and 2014. Setting: Twelve children’s hospitals in the United States. Patients: Two hundred twenty-two pediatric allogeneic hematopoietic stem cell transplant recipients with acute respiratory failure using invasive mechanical ventilation. Interventions: None. Measurements and Main Results: PICU mortality of our cohort was 60.4%. Mortality at 180 days post PICU discharge was 74%. Length of PICU stay prior to initiation of invasive mechanical ventilation was significantly lower in survivors, and the odds of mortality increased for longer length of PICU stay prior to intubation. A total of 91 patients (41%) received noninvasive ventilation at some point during their PICU stay prior to intubation. Noninvasive ventilation use preintubation was associated with increased mortality (odds ratio, 2.1; 95% CI, 1.2–3.6; p = 0.010). Patients ventilated longer than 15 days had higher odds of death (odds ratio, 2.4; 95% CI, 1.3–4.2; p = 0.004). Almost 40% of patients (n = 85) were placed on high-frequency oscillatory ventilation with a mortality of 76.5% (odds ratio, 3.3; 95% CI, 1.7–6.5; p = 0.0004). Of the 20 patients who survived high-frequency oscillatory ventilation, 18 were placed on high-frequency oscillatory ventilation no later than the third day of invasive mechanical ventilation. In this subset of 85 patients, transition to high-frequency oscillatory ventilation within 2 days of the start of invasive mechanical ventilation resulted in a 76% decrease in the odds of death compared with those who transitioned to high-frequency oscillatory ventilation later in the invasive mechanical ventilation course. Conclusions: This study suggests that perhaps earlier more aggressive critical care interventions in the pediatric hematopoietic stem cell transplant patient with respiratory failure requiring invasive mechanical ventilation may offer an opportunity to improve outcomes.


Critical Care Medicine | 2016

Combining Prognostic and Predictive Enrichment Strategies to Identify Children with Septic Shock Responsive to Corticosteroids

Hector R. Wong; Sarah J. Atkinson; Natalie Z. Cvijanovich; Nick Anas; Geoffrey L. Allen; Neal J. Thomas; Michael T. Bigham; Scott L. Weiss; Julie C. Fitzgerald; Paul A. Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J. Freishtat; Jeffrey Nowak; Shekhar S. Raj; Shira Gertz; Christopher J. Lindsell

Objectives:Prognostic and predictive enrichment strategies are fundamental tools of precision medicine. Identifying children with septic shock who may benefit from corticosteroids remains a challenge. We combined prognostic and predictive strategies to identify a pediatric septic shock subgroup responsive to corticosteroids. Design:We conducted a secondary analysis of 288 previously published pediatric subjects with septic shock. For prognostic enrichment, each study subject was assigned a baseline mortality probability using the pediatric sepsis biomarker risk model. For predictive enrichment, each study subject was allocated to one of two septic shock endotypes, based on a 100-gene signature reflecting adaptive immunity and glucocorticoid receptor signaling. The primary study endpoint was complicated course, defined as the persistence of two or more organ failures at day 7 of septic shock or 28-day mortality. We used logistic regression to test for an association between corticosteroids and complicated course within endotype. Measurements and Main Results:Among endotype B subjects at intermediate to high pediatric sepsis biomarker risk model-based risk of mortality, corticosteroids were independently associated with more than a 10-fold reduction in the risk of a complicated course (relative risk, 0.09; 95% CI, 0.01–0.54; p = 0.007). Conclusions:A combination of prognostic and predictive strategies based on serum protein and messenger RNA biomarkers can identify a subgroup of children with septic shock who may be more likely to benefit from corticosteroids. Prospective validation of these strategies and the existence of this subgroup are warranted.


Critical Care Medicine | 2015

A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney Injury.

Hector R. Wong; Natalie Z. Cvijanovich; Nick Anas; Geoffrey L. Allen; Neal J. Thomas; Michael T. Bigham; Scott L. Weiss; Julie C. Fitzgerald; Paul A. Checchia; Keith Meyer; Thomas P. Shanley; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J. Freishtat; Jeffrey Nowak; Shekhar S. Raj; Shira Gertz; Emily Dawson; Kelli Howard; Kelli Harmon; Patrick Lahni; Erin Frank; Kimberly W. Hart; Christopher J. Lindsell

Objective:The development of acute kidney injury in patients with sepsis is associated with worse outcomes. Identifying those at risk for septic acute kidney injury could help to inform clinical decision making. We derived and tested a multibiomarker-based model to estimate the risk of septic acute kidney injury in children with septic shock. Design:Candidate serum protein septic acute kidney injury biomarkers were identified from previous transcriptomic studies. Model derivation involved measuring these biomarkers in serum samples from 241 subjects with septic shock obtained during the first 24 hours of admission and then using a Classification and Regression Tree approach to estimate the probability of septic acute kidney injury 3 days after the onset of septic shock, defined as at least two-fold increase from baseline serum creatinine. The model was then tested in a separate cohort of 200 subjects. Setting:Multiple PICUs in the United States. Interventions:None other than standard care. Measurements and Main Results:The decision tree included a first-level decision node based on day 1 septic acute kidney injury status and five subsequent biomarker-based decision nodes. The area under the curve for the tree was 0.95 (CI95, 0.91–0.99), with a sensitivity of 93% and a specificity of 88%. The tree was superior to day 1 septic acute kidney injury status alone for estimating day 3 septic acute kidney injury risk. In the test cohort, the tree had an area under the curve of 0.83 (0.72–0.95), with a sensitivity of 85% and a specificity of 77% and was also superior to day 1 septic acute kidney injury status alone for estimating day 3 septic acute kidney injury risk. Conclusions:We have derived and tested a model to estimate the risk of septic acute kidney injury on day 3 of septic shock using a novel panel of biomarkers. The model had very good performance in a test cohort and has test characteristics supporting clinical utility and further prospective evaluation.


Critical Care Medicine | 2016

Pediatric Sepsis Biomarker Risk Model-ii: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype

Hector R. Wong; Natalie Z. Cvijanovich; Nick Anas; Geoffrey L. Allen; Neal J. Thomas; Michael T. Bigham; Scott L. Weiss; Julie C. Fitzgerald; Paul A. Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J. Freishtat; Jeffrey Nowak; Shekhar S. Raj; Shira Gertz; Kelli Howard; Kelli Harmon; Patrick Lahni; Erin Frank; Kimberly W. Hart; Trung C. Nguyen; Christopher J. Lindsell

Objective:The Pediatric Sepsis Biomarker Risk Model (PERSEVERE), a pediatric sepsis risk model, uses biomarkers to estimate baseline mortality risk for pediatric septic shock. It is unknown how PERSEVERE performs within distinct septic shock phenotypes. We tested PERSEVERE in children with septic shock and thrombocytopenia-associated multiple organ failure (TAMOF), and in those without new onset thrombocytopenia but with multiple organ failure (MOF). Design:PERSEVERE-based mortality risk was generated for each study subject (n = 660). A priori, we determined that if PERSEVERE did not perform well in both the TAMOF and the MOF cohorts, we would revise PERSEVERE to incorporate admission platelet counts. Setting:Multiple PICUs in the United States. Interventions:Standard care. Measurements and Main Results:PERSEVERE performed well in the TAMOF cohort (areas under the receiver operating characteristic curves [AUC], 0.84 [95% CI, 0.77–0.90]), but less well in the MOF cohort (AUC, 0.71 [0.61–0.80]). PERSEVERE was revised using 424 subjects previously reported in the derivation phase. PERSEVERE-II had an AUC of 0.89 (0.85–0.93) and performed equally well across TAMOF and MOF cohorts. PERSEVERE-II performed well when tested in 236 newly enrolled subjects. Sample size calculations for a clinical trial testing the efficacy of plasma exchange for children with septic shock and TAMOF indicated PERSEVERE-II–based stratification could substantially reduce the number of patients necessary, when compared with no stratification. Conclusions:Testing PERSEVERE in the context of septic shock phenotypes prompted a revision incorporating platelet count. PERSEVERE-II performs well upon testing, independent of TAMOF or MOF status. PERSEVERE-II could potentially serve as a prognostic enrichment tool.


Pediatric Critical Care Medicine | 2017

Pediatric Acute Respiratory Distress Syndrome in Pediatric Allogeneic Hematopoietic Stem Cell Transplants: A Multicenter Study

Courtney Rowan; Lincoln S. Smith; Ashley Loomis; Jennifer McArthur; Shira Gertz; Julie C. Fitzgerald; Mara Nitu; Elizabeth A. S. Moser; Deyin D. Hsing; Christine Duncan; Kris M. Mahadeo; Jerelyn Moffet; Mark W. Hall; Emily L. Pinos; Robert F. Tamburro; Ira M. Cheifetz

Objective: Immunodeficiency is both a preexisting condition and a risk factor for mortality in pediatric acute respiratory distress syndrome. We describe a series of pediatric allogeneic hematopoietic stem cell transplant patients with pediatric acute respiratory distress syndrome based on the recent Pediatric Acute Lung Injury Consensus Conference guidelines with the objective to better define survival of this population. Design: Secondary analysis of a retrospective database. Setting: Twelve U.S. pediatric centers. Patients: Pediatric allogeneic hematopoietic stem cell transplant recipients requiring mechanical ventilation. Interventions: None. Measurements and Main Results: During the first week of mechanical ventilation, patients were categorized as: no pediatric acute respiratory distress syndrome or mild, moderate, or severe pediatric acute respiratory distress syndrome based on oxygenation index or oxygen saturation index. Univariable logistic regression evaluated the association between pediatric acute respiratory distress syndrome and PICU mortality. A total of 91.5% of the 211 patients met criteria for pediatric acute respiratory distress syndrome using the Pediatric Acute Lung Injury Consensus Conference definition: 61.1% were severe, 27.5% moderate, and 11.4% mild. Overall survival was 39.3%. Survival decreased with worsening pediatric acute respiratory distress syndrome: no pediatric acute respiratory distress syndrome 66.7%, mild 63.6%, odds ratio = 1.1 (95% CI, 0.3–4.2; p = 0.84), moderate 52.8%, odds ratio = 1.8 (95% CI, 0.6–5.5; p = 0.31), and severe 24.6%, odds ratio = 6.1 (95% CI, 2.1–17.8; p < 0.001). Nonsurvivors were more likely to have multiple consecutive days at moderate and severe pediatric acute respiratory distress syndrome (p < 0.001). Moderate and severe patients had longer PICU length of stay (p = 0.01) and longer mechanical ventilation course (p = 0.02) when compared with those with mild or no pediatric acute respiratory distress syndrome. Nonsurvivors had a higher median maximum oxygenation index than survivors at 28.6 (interquartile range, 15.5–49.9) versus 15.0 (interquartile range, 8.4–29.6) (p < 0.0001). Conclusion: In this multicenter cohort, the majority of pediatric allogeneic hematopoietic stem cell transplant patients with respiratory failure met oxygenation criteria for pediatric acute respiratory distress syndrome based on the Pediatric Acute Lung Injury Consensus Conference definition within the first week of invasive mechanical ventilation. Length of invasive mechanical ventilation, length of PICU stay, and mortality increased as the severity of pediatric acute respiratory distress syndrome worsened.


American Journal of Respiratory and Critical Care Medicine | 2017

Improved Risk Stratification in Pediatric Septic Shock Using Both Protein and mRNA Biomarkers. PERSEVERE-XP

Hector R. Wong; Natalie Z. Cvijanovich; Nick Anas; Geoffrey L. Allen; Neal J. Thomas; Michael T. Bigham; Scott L. Weiss; Julie C. Fitzgerald; Paul A. Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J. Freishtat; Jeffrey Nowak; Shekhar S. Raj; Shira Gertz; Jocelyn R. Grunwell; Christopher J. Lindsell

Rationale: We previously derived and validated the Pediatric Sepsis Biomarker Risk Model (PERSEVERE) to estimate baseline mortality risk in children with septic shock. The PERSEVERE biomarkers are serum proteins selected from among the proteins directly related to 80 mortality risk assessment genes. The initial approach to selecting the PERSEVERE biomarkers left 68 genes unconsidered. Objectives: To determine if the 68 previously unconsidered genes can improve upon the performance of PERSEVERE and to provide biological information regarding the pathophysiology of septic shock. Methods: We reduced the number of variables by determining the biological linkage of the 68 previously unconsidered genes. The genes identified through variable reduction were combined with the PERSEVERE‐based mortality probability to derive a risk stratification model for 28‐day mortality using classification and regression tree methodology (n = 307). The derived tree, PERSEVERE‐XP, was then tested in a separate cohort (n = 77). Measurements and Main Results: Variable reduction revealed a network consisting of 18 mortality risk assessment genes related to tumor protein 53 (TP53). In the derivation cohort, PERSEVERE‐XP had an area under the receiver operating characteristic curve (AUC) of 0.90 (95% confidence interval, 0.85‐0.95) for differentiating between survivors and nonsurvivors. In the test cohort, the AUC was 0.96 (95% confidence interval, 0.91‐1.0). The AUC of PERSEVERE‐XP was superior to that of PERSEVERE. Conclusions: PERSEVERE‐XP combines protein and mRNA biomarkers to provide mortality risk stratification with possible clinical utility. PERSEVERE‐XP significantly improves on PERSEVERE and suggests a role for TP53‐related cellular division, repair, and metabolism in the pathophysiology of septic shock.


EBioMedicine | 2015

Prospective Testing and Redesign of a Temporal Biomarker Based Risk Model for Patients With Septic Shock: Implications for Septic Shock Biology

Hector R. Wong; Natalie Z. Cvijanovich; Nick Anas; Geoffrey L. Allen; Neal J. Thomas; Michael T. Bigham; Scott L. Weiss; Julie C. Fitzgerald; Paul A. Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J. Freishtat; Jeffrey Nowak; Shekhar S. Raj; Shira Gertz; Kelli Howard; Kelli Harmon; Patrick Lahni; Erin Frank; Kimberly W. Hart; Christopher J. Lindsell

The temporal version of the pediatric sepsis biomarker risk model (tPERSEVERE) estimates the risk of a complicated course in children with septic shock based on biomarker changes from days 1 to 3 of septic shock. We validated tPERSEVERE performance in a prospective cohort, with an a priori plan to redesign tPERSEVERE if it did not perform well. Biomarkers were measured in the validation cohort (n = 168) and study subjects were classified according to tPERSEVERE. To redesign tPERSEVERE, the validation cohort and the original derivation cohort (n = 299) were combined and randomly allocated to training (n = 374) and test (n = 93) sets. tPERSEVERE was redesigned using the training set and CART methodology. tPERSEVERE performed poorly in the validation cohort, with an area under the curve (AUC) of 0.67 (95% CI: 0.58–0.75). Failure analysis revealed potential confounders related to clinical characteristics. The redesigned tPERSEVERE model had an AUC of 0.83 (0.79–0.87) and a sensitivity of 93% (68–97) for estimating the risk of a complicated course. Similar performance was seen in the test set. The classification tree segregated patients into two broad endotypes of septic shock characterized by either excessive inflammation or immune suppression.


Pediatric Critical Care Medicine | 2018

Hyperchloremia Is Associated with Complicated Course and Mortality in Pediatric Patients with Septic Shock

Erin K. Stenson; Natalie Z. Cvijanovich; Nick Anas; Geoffrey L. Allen; Neal J. Thomas; Michael T. Bigham; Scott L. Weiss; Julie C. Fitzgerald; Paul A. Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J. Freishtat; Jeffrey Nowak; Shekhar S. Raj; Shira Gertz; Jocelyn R. Grunwell; Hector R. Wong

Objective: Hyperchloremia is associated with poor outcome among critically ill adults, but it is unknown if a similar association exists among critically ill children. We determined if hyperchloremia is associated with poor outcomes in children with septic shock. Design: Retrospective analysis of a pediatric septic shock database. Setting: Twenty-nine PICUs in the United States. Patients: Eight hundred ninety children 10 years and younger with septic shock. Interventions: None. Measurements and Main Results: We considered the minimum, maximum, and mean chloride values during the initial 7 days of septic shock for each study subject as separate hyperchloremia variables. Within each category, we considered hyperchloremia as a dichotomous variable defined as a serum concentration greater than or equal to 110 mmol/L. We used multivariable logistic regression to determine the association between the hyperchloremia variables and outcome, adjusted for illness severity. We considered all cause 28-day mortality and complicated course as the primary outcome variables. Complicated course was defined as mortality by 28 days or persistence of greater than or equal to two organ failures at day 7 of septic shock. Secondarily, we conducted a stratified analysis using a biomarker-based mortality risk stratification tool. There were 226 patients (25%) with a complicated course and 93 mortalities (10%). Seventy patients had a minimum chloride greater than or equal to 110 mmol/L, 179 had a mean chloride greater than or equal to 110 mmol/L, and 514 had a maximum chloride greater than or equal to 110 mmol/L. A minimum chloride greater than or equal to 110 mmol/L was associated with increased odds of complicated course (odds ratio, 1.9; 95% CI, 1.1–3.2; p = 0.023) and mortality (odds ratio, 3.7; 95% CI, 2.0–6.8; p < 0.001). A mean chloride greater than or equal to 110 mmol/L was also associated with increased odds of mortality (odds ratio, 2.1; 95% CI, 1.3–3.5; p = 0.002). The secondary analysis yielded similar results. Conclusion: Hyperchloremia is independently associated with poor outcomes among children with septic shock.


Pediatric Critical Care Medicine | 2017

Glucocorticoid Receptor Polymorphisms and Outcomes in Pediatric Septic Shock.

Natalie Z. Cvijanovich; Nick Anas; Geoffrey L. Allen; Neal J. Thomas; Michael T. Bigham; Scott L. Weiss; Julie C. Fitzgerald; Paul A. Checchia; Keith Meyer; Michael Quasney; Rainer Gedeit; Robert J. Freishtat; Jeffrey Nowak; Shekhar S. Raj; Shira Gertz; Jocelyn R. Grunwell; Amy Opoka; Hector R. Wong

Objective: Polymorphisms of the glucocorticoid receptor gene are associated with outcome and corticosteroid responsiveness among patients with inflammatory disorders. We conducted a candidate gene association study to test the hypothesis that these polymorphisms are associated with outcome and corticosteroid responsiveness among children with septic shock. Design: We genotyped 482 children with septic shock for the presence of two glucocorticoid receptor polymorphisms (rs56149945 and rs41423247) associated with increased sensitivity and one glucocorticoid receptor polymorphism (rs6198) associated with decreased sensitivity to corticosteroids. The primary outcome variable was complicated course, defined as 28-day mortality or the persistence of two or more organ failures 7 days after a septic shock diagnosis. We used logistic regression to test for an association between corticosteroid exposure and outcome, within genotype group, and adjusted for illness severity. Setting: Multiple PICUs in the United States. Interventions: Standard care. Measurements and Main Results: There were no differences in outcome when comparing the various genotype groups. Among patients homozygous for the wild-type glucocorticoid receptor allele, corticosteroids were independently associated with increased odds of complicated course (odds ratio, 2.30; 95% CI, 1.01–5.21; p = 0.047). Conclusions: Based on these glucocorticoid receptor polymorphisms, we could not detect a beneficial effect of corticosteroids among any genotype group. Among children homozygous for the wild-type allele, corticosteroids were independently associated with increased odds of poor outcome.

Collaboration


Dive into the Shira Gertz's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mark Hall

Nationwide Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Neal J. Thomas

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Scott L. Weiss

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hector R. Wong

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Keith Meyer

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Michael Quasney

Children's Hospital of Wisconsin

View shared research outputs
Researchain Logo
Decentralizing Knowledge